Skip to main content

Table 1 Total number of differentially regulated genes

From: Distinct gene regulatory programs define the inhibitory effects of liver X receptors and PPARG on cancer cell proliferation

  24-h treatment 48-h treatment
  Fold change ≥1.5 Fold change ≤ −1.5 Fold change ≥2 Fold change ≤ −2 Fold change ≥1.5 Fold change ≤ −1.5 Fold change ≥2 Fold change ≤ −2
Rosiglitazone 421 646 273 177 1019 1396 416 701
GW3965 223 83 100 24 1846 1646 698 535
T0901317 161 10 57 1 1538 1578 589 560
GW3965 + T0901317 119 5 47 0 1040 1141 357 395
  1. The total number of differentially regulated genes (up- and down-regulated) using two distinct fold change cutoffs (p < 0.01) from all drug treatments at 24- and 48-h time points is shown. For GW3965 + T0901317 high confidence LXR target gene analyses, all genes exceeded fold change and p value cutoffs across both drug treatments